http://orcid.org/0000-0001-8318-667X
References
- He D, Marles-Wright J. Ferritin family proteins and their use in bionanotechnology. N Biotechnol. 2015;32:651–657.
- Ponka P, Richardson DR. Can ferritin provide iron for hemoglobin synthesis? Blood. 1997;89:2611–2613.
- Chi EY, Krishnan S, Randolph TW, et al. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res. 2003;20:1325–1336.
- Maham A, Tang Z, Wu H, et al. Protein-based nanomedicine platforms for drug delivery. Small. 2009;5:1706–1721.
- De Groot AS, Scott DW. Immunogenicity of protein, therapeutics. Trends Immunol. 2007;28:482–490.
- Lofgren JA, Wala I, Koren E, et al. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein. J Immunol Methods. 2006;308:101–108.
- Wadhwa M, Meager A, Dilger P, et al. Neutralizing antibodies to granulocyte–macrophage colony stimulating factor (GM–CSF), interleukin-1α (IL-1α) and interferon-α (IFN-α), but not other cytokines in human immunoglobulin preparations. Immunology. 2000;99:113–123.
- Kilic MA, Ozlu E, Calis S. A novel protein-based anticancer drug encapsulating nanosphere: apo-doxorubicin complex. J Biomed Nanotechnol. 2012;8:508–514.
- Ji X-T, Huang L, Huang H-Q. Construction of nanometer cisplatin core-ferritin (NCC-F) and proteomic analysis of gastric cancer cell apoptosis induced with cisplatin released from the NCC-F. J Proteomics. 2012;75:3145–3157.
- Zhang L, Li L, Di Penta A, et al. H-chain ferritin: a natural nuclei targeting and bioactive delivery nanovector. Adv Healthc Mater. 2015;4:1305–1310.
- Li X, Qiu LH, Zhu P, et al. Epidermal growth factor-ferritin h-chain protein nanoparticles for tumor active targeting. Small. 2012;8:2505–2514.